Drug interactions
Asenapine transdermal + Indacaterol-glycopyrronium
Severity: Moderate
Asenapine transdermal and Indacaterol-glycopyrronium: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Asenapine has a modest QT-prolonging effect, and indacaterol may add to cardiac repolarization effects. The combined risk is generally small but relevant in patients with other arrhythmia risk factors.
What this interaction means in plain words
Asenapine transdermal and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive QT prolongation and beta2-agonist cardiac stimulation.
What to do
Monitor ECG and electrolytes in patients with cardiac disease or other QT-prolonging drugs. Report palpitations or fainting promptly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Asenapine transdermal and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Frequently asked questions
Can I take Asenapine transdermal with Indacaterol-glycopyrronium?
MediHelp rates the interaction as moderate. Asenapine transdermal and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Asenapine has a modest QT-prolonging effect, and indacaterol may add to cardiac repolarization effects. The combined risk is generally small but relevant in patients with other arrhythmia risk factors.
How serious is the interaction between Asenapine transdermal and Indacaterol-glycopyrronium?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and electrolytes in patients with cardiac disease or other QT-prolonging drugs. Report palpitations or fainting promptly.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
